ORKAOruka Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 19730
Ticker: ORKA
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2024-09-03
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: ORKA

Detail

Enriched 2026-08-14 20:47

Market cap: $7,110,921,672.6
Shares outstanding (class): 60,312,101
Shares outstanding (weighted): 66,209,699
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 68
Location: MENLO PARK, CA
Homepage: https://www.orukatx.com
Description: Oruka Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its programs are to treat and potentially modify disease by targeting mechanisms with efficacy and safety involved in disease pathology and the activity of pathogenic tissue-resident memory T cells (TRMs). Its program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. Its co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, hidradenitis suppurativa (HS), psoriatic arthritis (PsA), and other conditions.

Market cap and share counts drift.

Funds holding this security

75 funds · 78 positions · $277.80M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$67.43M	0.00%	1,374,750 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$46.31M	0.06%	944,174 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$37.33M	0.50%	761,033 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$23.35M	0.21%	476,018 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$21.45M	0.03%	437,253 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$16.24M	0.13%	331,074 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$14.93M	0.18%	304,331 NS	FIGI
VIP Health Care Portfolio Variable Insurance Products Fund IV	—	$7.95M	0.79%	162,159 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$4.77M	0.39%	97,232 NS	FIGI
abrdn Life Sciences Investors —	—	$3.71M	0.66%	75,680 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$3.06M	0.06%	62,331 NS	FIGI
iShares Core S&P Total U.S. Stock Market ETF iShares Trust	ITOT	$2.78M	0.00%	56,644 NS	FIGI
BlackRock Health Sciences Term Trust —	—	$2.38M	0.23%	48,426 NS	FIGI
Fidelity Small Cap Value Index Fund Fidelity Salem Street Trust	—	$2.34M	0.13%	47,743 NS	FIGI
EQ/2000 Managed Volatility Portfolio EQ Advisors Trust	—	$1.96M	0.06%	40,003 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERORKA
FIGI_COMPOSITEBBG000BWNN28
FIGI_SHARE_CLASSBBG001SB1GL2
CIK0000907654
ISINUS6876041087
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Common stock with SIC 2834 indicates pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.